Intervention 1: Intervention group: patients are treated by intravenous injection of 5 times supernatant culture medium of allogeneic menstrual blood-derived stem cells. After isolation and culture in

2 trials

Sponsors

Iranian academic center for education culture and research

Conditions

moderate to severe covid-19 patients. COVID-19, virus identifiedsevere covid-19 patients. COVID-19, virus identified

Phase 2

menstrual blood stem cell therapy for covid-19

Active, not recruitingIRCT20180619040147N6

Iranian academic center for education culture and researchsevere covid-19 patients. COVID-19, virus identified

Start: 2021-04-21Target: 30Updated: 2021-04-26

Phase 3

Treatment of Covid-19 using menstrual blood stem cell secretome

RecruitingIRCT20180619040147N7

Iranian academic center for education culture and researchmoderate to severe covid-19 patients. COVID-19, virus identified

Start: 2021-07-23Target: 90Updated: 2021-08-30

Related Papers

Safety and efficacy study of allogeneic human menstrual blood stromal cells secretome to treat severe COVID-19 patients: clinical trial phase I & II.

2022-03-0738 citations